Brigent Specialty Pharmacy

Overview

Brigent Specialty Pharmacy is a Los Angeles-based pharmacy that combines specialty medication dispensing with compounding services and home infusion therapy — a hybrid model that distinguishes it from conventional specialty pharmacies (Brigent). The pharmacy covers therapeutic areas including dermatology, hematology/oncology, immunology, neurology, pediatrics, and rheumatology (Brigent Specialties).

The compounding arm produces customized medications in forms including creams, gels, troches, suppositories, capsules, transdermal preparations, lollipops, and solutions. Compounding use cases include pain management (corticosteroids, muscle relaxants, NSAIDs in transdermal gels), wound care, hospice/palliative care, long-term care, and pediatric formulations where commercial dosage forms are unavailable or inappropriate (Brigent Pain Management; Brigent Long-Term Care; Brigent Wound Care).

The home infusion arm administers IVIG, SCIG, monoclonal antibody therapies, injectables, and pegloticase (for chronic refractory gout). Infusion services include PICC line and port access/care, medication reconciliation, 24/7 advice nursing, and pre-certification/billing support (Brigent Home Infusion).

Classification Note

Brigent is more accurately classified as a specialty compounding pharmacy with home infusion services rather than a traditional specialty pharmacy in the LDN/manufacturer-partnership sense. Its inclusion in a specialty pharmacy directory should note this distinction. Compounding pharmacies operate under different regulatory frameworks (FDA Section 503A/503B) than traditional specialty pharmacies and typically do not participate in manufacturer LDN or REMS programs for branded drugs.

The “IVI Pharmacy” branding that appears on some Brigent subpages and on Instagram (based in Calabasas, CA) suggests either a rebranding or a related entity (Instagram @ivipharmacy).

Accreditations

Not publicly listed. No URAC or ACHC accreditation identified — a significant gap if the pharmacy intends to compete for manufacturer specialty contracts.

Competitive Positioning

Brigent occupies a fundamentally different market position than conventional specialty pharmacies like Amber or Senderra. It is best understood as a compounding-first specialty pharmacy with home infusion capabilities, serving a local/regional market in the greater Los Angeles area.

This model does not compete directly with PBM-affiliated SPs or large independent SPs for LDN-distributed drugs from major manufacturers. Instead, Brigent serves physicians and patients who need:

• Customized formulations not available commercially (pediatric dosing, alternative delivery forms, combination preparations)
• Home infusion for immunology and rheumatology patients who prefer at-home treatment
• Hospice and long-term care compounding for facilities in the LA area

Recent Developments (2024–2026)

• May 2024: George Gitau appointed Chief Operating Officer, promoted from VP of Specialty Operations (LinkedIn).
• No press releases, funding announcements, or partnerships identified in public sources for 2024–2026.
• No URAC or ACHC accreditation publicly listed — a significant gap if the pharmacy intends to compete for manufacturer specialty contracts.

Client & Partner Ecosystem

Brigent’s client base appears to consist primarily of:

• Local physician practices in the Los Angeles/Calabasas area who need compounded formulations
• Home health agencies and hospice providers requiring customized medications
• Individual patients with chronic conditions requiring home infusion (immunodeficiency, autoimmune, chronic gout)

There is no evidence of direct pharmaceutical manufacturer partnerships or LDN contracts.

Technology Platform

Brigent describes using “advanced pharmaceutical equipment, technology, and techniques” on its website (Brigent), but does not detail specific pharmacy management systems, patient portals, or data reporting capabilities. The 24/7 advice nursing service is notable for a small pharmacy. No evidence of EHR integration, patient-facing digital tools, or outcomes reporting platforms.

Therapeutic Focus

Dermatology, hematology/oncology, immunology, neurology, pediatrics, rheumatology. Compounding specialties: pain management, wound care, hospice/palliative care, long-term care, pediatric formulations.

Key Leadership

• George Gitau — Chief Operating Officer (since May 2024; promoted from VP of Specialty Operations)

Financial Context

Brigent appears to be a small, independently owned specialty compounding pharmacy. No revenue figures, funding rounds, or PE involvement have been identified. Employee count is estimated at fewer than 50 based on LinkedIn presence and local scope. The pharmacy appears to serve the greater Los Angeles market rather than operating nationally.

The compounding pharmacy market is distinct from the specialty pharmacy market — compounding margins can be high on a per-prescription basis, but total addressable market is smaller and more fragmented.

Estimated revenue: <$10M (estimated)

Analyst Observations

Strengths: The compounding + home infusion combination addresses a genuine gap, particularly for pain management, pediatric, hospice, and immunology patients who need customized formulations with professional infusion administration. The LA market is large enough to sustain a local compounding operation.

Risks: Without URAC or ACHC accreditation (or at least none publicly listed), Brigent cannot access LDN-distributed specialty drugs from manufacturers. The FDA’s increasing scrutiny of compounding pharmacies (503A vs. 503B classification, interstate distribution limits under the MOU framework) creates regulatory risk. Scale is limited by local focus.

Acquisition potential: Low for traditional SP acquirers. Potentially interesting to home infusion platforms (e.g., BrightSpring/PharMerica, Option Care Health) looking for LA market density, or to compounding rollup platforms (e.g., Fagron, ImprimisRx/Harrow Health) for geographic expansion.

Category Links

• Primary category: Specialty Pharmacies
• Secondary: Infusion & Clinical Services

Sources

• Brigent.com homepage, Brigent Specialties, Brigent Home Infusion, Brigent Pain Management, IVI Pharmacy Long-Term Care, IVI Pharmacy Wound Care, Instagram @ivipharmacy, LinkedIn George Gitau, About Us